CU6 1.41% $6.46 clarity pharmaceuticals ltd

Ann: First patient dosed in Phase III prostate cancer trial, page-11

  1. 2,489 Posts.
    lightbulb Created with Sketch. 503
    I think I have underbought here damn it
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.